Challenges in Management of Thoracic Malignancies in Patients with COPD

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Thoracic Oncology".

Deadline for manuscript submissions: 31 March 2025 | Viewed by 407

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pulmonology, Internal Medicine II, Vienna University Hospital, Vienna, Austria
Interests: COPD; asthma; interventional pulmonology; lung cancer

E-Mail Website
Guest Editor
2nd Respiratory Medicine Department, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece
Interests: asthma; COPD; pulmonology; lung disease
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Chronic obstructive pulmonary disease (COPD) poses a significant social burden, as it has a widespread effect on healthcare systems, the economy, and social welfare. In 2016, there were over 251 million COPD cases recorded. Approximately 3 million deaths are attributed to COPD, which makes up to 6% of all deaths globally. According to the World Health Organization (WHO), COPD will become the third most common cause of death by 2030, due to ongoing exposure to smoke and the aging of the population.

The complex interplay between COPD and thoracic malignancies, particularly lung cancer, is a subject of significant medical interest and concern. The treatment of COPD patients, especially those with malignancies, remains a formidable challenge. Also, COPD complicates the management of lung cancer and other thoracic malignancies, affecting diagnosis, treatment, and prognosis.

We invite potential contributors to submit their work on current challenges in treating COPD patients with lung cancer or secondary pulmonary malignancies. We are particularly interested in manuscripts addressing survival predictors, postoperative/postinterventional risk factors, and novel therapy strategies or regimens. Submissions may include original research articles, narrative reviews, and systematic reviews.

This Special Issue aims to compile cutting-edge research and expert reviews that will enhance our understanding and treatment of this complex patient population.

We look forward to receiving your valuable contributions.

Dr. Anastasia Papaporfyriou
Dr. Κonstantinos Bartziokas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COPD
  • lung cancer
  • secondary pulmonary metastases
  • immunotherapy
  • targeted therapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop